Published in Oncology on February 07, 2012
Hepatocellular carcinoma: Where there is unmet need. Mol Oncol (2015) 0.93
Efficacy and safety of bevacizumab for the treatment of advanced hepatocellular carcinoma: a systematic review of phase II trials. PLoS One (2012) 0.91
Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives. Onco Targets Ther (2014) 0.84
Targeted therapies in the treatment of advanced hepatocellular carcinoma. Clin Med Insights Oncol (2013) 0.83
Comparative dosing and efficacy of sorafenib in hepatocellular cancer patients with varying liver dysfunction. J Gastrointest Oncol (2015) 0.81
Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies. World J Hepatol (2012) 0.81
Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety. Cancer Manag Res (2013) 0.80
A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features. BMC Cancer (2015) 0.79
Treating hepatocellular carcinoma progression following first-line sorafenib: therapeutic options and clinical observations. Therap Adv Gastroenterol (2013) 0.78
Development of systemic therapy for hepatocellular carcinoma at 2013: updates and insights. World J Gastroenterol (2014) 0.78
Optimal combination of antiangiogenic therapy for hepatocellular carcinoma. World J Hepatol (2015) 0.78
First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary study. Int J Clin Oncol (2015) 0.78
Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma. Onco Targets Ther (2016) 0.78
Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation. World J Gastroenterol (2015) 0.77
Erlotinib for advanced hepatocellular carcinoma. A systematic review of phase II/III clinical trials. Saudi Med J (2016) 0.75
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway? Onco Targets Ther (2017) 0.75
Mixed response and time-to-event endpoints for multistage single-arm phase II design. Trials (2015) 0.75
Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer. Pharmacogenomics J (2016) 0.75
Targeting the vasculature in hepatocellular carcinoma treatment: Starving versus normalizing blood supply. Clin Transl Gastroenterol (2017) 0.75
Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy. Diseases (2015) 0.75
Antiangiogenic agents after first line and sorafenib plus chemoembolization: a systematic review. Oncotarget (2017) 0.75
Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA (1995) 11.90
A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry (1996) 7.80
Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell (1991) 6.49
Differences in the use of psychiatric outpatient services between the United States and Ontario. N Engl J Med (1997) 4.78
Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry (1999) 4.57
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A (2007) 4.16
Childhood abuse and lifetime psychopathology in a community sample. Am J Psychiatry (2001) 4.07
Genetic polymorphism among Cryptosporidium parvum isolates: evidence of two distinct human transmission cycles. Emerg Infect Dis (1997) 4.02
Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol (1992) 3.41
The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res (1999) 3.36
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma. J Clin Oncol (2007) 3.07
Adequacy and duration of antidepressant treatment in primary care. Med Care (1992) 3.04
Dissociable neural responses to facial expressions of sadness and anger. Brain (1999) 2.94
Transdermal nicotine for active ulcerative colitis. N Engl J Med (1994) 2.90
Differentiating human from animal isolates of Cryptosporidium parvum. Emerg Infect Dis (1999) 2.89
Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria. Br J Surg (2010) 2.83
Rethinking practitioner roles in chronic illness: the specialist, primary care physician, and the practice nurse. Gen Hosp Psychiatry (2001) 2.82
Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst (2000) 2.77
Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol (1997) 2.75
Purification and characterization of two components of botulinum C2 toxin. Infect Immun (1980) 2.74
Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma. J Clin Oncol (2009) 2.69
Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol (2008) 2.52
First measurement of kaonic helium-3 X-rays. Phys Lett B (2011) 2.37
Dietary fish oil reduces O6-methylguanine DNA adduct levels in rat colon in part by increasing apoptosis during tumor initiation. Cancer Epidemiol Biomarkers Prev (2000) 2.33
Molecular characterization of Cryptosporidium isolates obtained from human immunodeficiency virus-infected individuals living in Switzerland, Kenya, and the United States. J Clin Microbiol (2000) 2.32
The Drosophila RAD21 cohesin persists at the centromere region in mitosis. Curr Biol (2000) 2.29
Neurological disorders and adult coeliac disease. Gut (1970) 2.29
Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res (2001) 2.27
Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci U S A (1989) 2.25
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol (2001) 2.24
DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes. J Clin Oncol (2009) 2.23
A validated whole-genome association study of efficient food conversion in cattle. Genetics (2007) 2.23
Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels. J Intern Med (2013) 2.22
Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Environ Health Perspect (1998) 2.22
Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma. Clin Cancer Res (2009) 2.21
One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. Can J Psychiatry (1996) 2.18
Fission yeast Eso1p is required for establishing sister chromatid cohesion during S phase. Mol Cell Biol (2000) 2.17
Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev (1993) 2.15
Prospective study of serum micronutrients and ovarian cancer. J Natl Cancer Inst (1996) 2.15
Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry (1990) 2.13
Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma. Br J Cancer (2007) 2.09
Variation in Cryptosporidium: towards a taxonomic revision of the genus. Int J Parasitol (1999) 2.07
Somatization: a spectrum of severity. Am J Psychiatry (1991) 2.03
Skin lesions during intravenous hyperalimentation: zinc deficiency. 1976. Nutrition (1992) 2.03
Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr (1992) 2.02
A randomized trial of psychiatric consultation with distressed high utilizers. Gen Hosp Psychiatry (1992) 2.00
Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant (2007) 2.00
Selenium, retinol, retinol-binding protein, and uric acid. Associations with cancer mortality in a population-based prospective case-control study. Ann Epidemiol (1991) 1.98
Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res (2001) 1.97
Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br J Cancer (2013) 1.96
Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties. Infect Immun (1977) 1.92
Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Clin Cancer Res (2006) 1.91
Bulimia nervosa in a Canadian community sample: prevalence and comparison of subgroups. Am J Psychiatry (1995) 1.90
CpG island methylation in colorectal adenomas. Am J Pathol (2001) 1.88
Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. J Clin Oncol (2009) 1.88
A comparison of Cryptosporidium subgenotypes from several geographic regions. J Eukaryot Microbiol (2001) 1.86
Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst (1995) 1.85
A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry (2001) 1.83
Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. Am J Physiol Lung Cell Mol Physiol (2007) 1.82
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. Antimicrob Agents Chemother (1996) 1.80
Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol (2001) 1.80
Production of extracellular enzymes and cytotoxicity by Vibrio vulnificus. Diagn Microbiol Infect Dis (1986) 1.79
Mental health supplement to the Ontario Health Survey: methodology. Can J Psychiatry (1996) 1.79
Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]. Ann Surg Oncol (1998) 1.78
Comparison of homozygous sickle cell disease in northern Greece and Jamaica. Lancet (1990) 1.78
Medication management of depression in the United States and Ontario. J Gen Intern Med (1998) 1.78
Evidence that botulinum C2 toxin has two dissimilar components. Infect Immun (1980) 1.77
Phylogenetic relationships of Cryptosporidium parasites based on the 70-kilodalton heat shock protein (HSP70) gene. Appl Environ Microbiol (2000) 1.76
High-resolution serum proteomic patterns for ovarian cancer detection. Endocr Relat Cancer (2004) 1.76
Neurologic complications of surgery for cervical compression myelopathy. Spine (Phila Pa 1976) (1991) 1.76
Hepatocellular carcinoma with portal vein tumor thrombus: embolization of arterioportal shunts. Radiology (1997) 1.74
Space, time and persistence of virulent pathogens. Proc Biol Sci (1996) 1.74
Laminoplasty versus subtotal corpectomy. A comparative study of results in multisegmental cervical spondylotic myelopathy. Spine (Phila Pa 1976) (1992) 1.73
Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial. AIDS (1997) 1.73
Are there detectable differences in quality of care or outcome of depression across primary care providers? Med Care (2000) 1.72
Diagnositic value of serum bile acid estimations in liver disease. J Clin Pathol (1975) 1.71
Crossmodal binding of fear in voice and face. Proc Natl Acad Sci U S A (2001) 1.71
Coeliac infertility: an indication for dietary gluten restriction? Lancet (1970) 1.69
Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. Am J Epidemiol (2000) 1.69
The need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas (1996) 1.68
Long-term follow-up results of laminectomy for cervical myelopathy caused by ossification of the posterior longitudinal ligament. J Neurosurg (1998) 1.67
Neural activity associated with episodic memory for emotional context. Neuropsychologia (2001) 1.65
An age-structured model to evaluate the potential of novel malaria-control interventions: a case study of fungal biopesticide sprays. Proc Biol Sci (2009) 1.63
A population genetic study of the Cryptosporidium parvum human genotype parasites. J Eukaryot Microbiol (2001) 1.63
Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer. Br J Cancer (2012) 1.61
Behçet's syndrome: severe proctitis with rectovaginal fistula formation. Ann Rheum Dis (1989) 1.61
Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma. Clin Cancer Res (1999) 1.60
Novel role for JNK as a stress-activated Bcl2 kinase. J Biol Chem (2001) 1.60
The education of depressed primary care patients: what do patients think of interactive booklets and a video? J Fam Pract (1997) 1.59
Adhesion-dependent regulation of an A+U-rich element-binding activity associated with AUF1. Mol Cell Biol (1997) 1.59
A multispecialty approach to the diagnosis and management of pancreatic cancer. Am J Gastroenterol (2000) 1.58
Ethical difficulties in clinical practice: experiences of European doctors. J Med Ethics (2007) 1.57
Arsenic and noncirrhotic portal hypertension. Gastroenterology (1974) 1.57
Molecular and phylogenetic characterisation of Cryptosporidium from birds. Int J Parasitol (2001) 1.55
Verification of the Acute Physiology and Chronic Health Evaluation scoring system in a Hong Kong intensive care unit. Crit Care Med (1993) 1.55
Prediagnostic serum selenium and risk of cancer. Lancet (1983) 1.54
A prospective study of selenium status and breast cancer risk. JAMA (1990) 1.53